BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8836391)

  • 21. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency.
    Colao A; Di Somma C; Rota F; Pivonello R; Savanelli MC; Spiezia S; Lombardi G
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2056-62. PubMed ID: 15671089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient.
    Cacciari E; Tassoni P; Parisi G; Pirazzoli P; Zucchini S; Mandini M; Cicognani A; Balsamo A
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1284-9. PubMed ID: 1592872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
    Pfeifer M; Verhovec R; Zizek B; Prezelj J; Poredos P; Clayton RN
    J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults.
    Wieringa G; Toogood AA; Ryder WD; Anderson JM; Mackness M; Shalet SM
    Growth Horm IGF Res; 2000 Feb; 10(1):14-9. PubMed ID: 10753588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The adult patient with a congenital GH deficiency. Cholesterol-lowering effects of therapy with biosynthetic GH].
    Sartorio A; Conti A; Monzani M; Morabito F
    Minerva Endocrinol; 1994 Mar; 19(1):13-8. PubMed ID: 8035766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
    Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
    Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C; Johannsson G; Bengtsson BA; Svensson J
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency.
    Kohno H; Ueyama N; Yanai S; Ukaji K; Honda S
    J Pediatr; 1995 Jun; 126(6):953-5. PubMed ID: 7776105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term growth hormone therapy increases serum lipoprotein (a) levels in normal short children without growth hormone deficiency.
    Hershkovitz E; Leiberman E; Limony Y; Shany S; Phillip M
    Horm Res; 1996 Jul; 46(1):38-40. PubMed ID: 8854138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase of serum lipoprotein (a), an adverse effect of growth hormone treatment.
    Laron Z
    Growth Horm IGF Res; 2022 Dec; 67():101503. PubMed ID: 36115257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to European Journal of Endocrinology 1997 137 459-466 and 450-452: Effect of GH on lipoprotein (A) in GH deficiency.
    Laron Z
    Eur J Endocrinol; 1998 Apr; 138(4):440. PubMed ID: 9578514
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth hormone (GH)-deficiency in adults: clinical features and effects of GH substitution.
    Jørgensen JO; Møller J; Wolthers T; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
    J Pediatr Endocrinol; 1994; 7(4):283-93. PubMed ID: 7735365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.